Eight strains of a new intermediate adenovirus were isolated in the course of an investigation of conjunctivitis in Hiroshima City, Japan. The strain was first isolated in July 1986. All eight strains were isolated from conjunctival swab samples from patients with conjunctivitis, mainly epidemic keratoconjunctivitis. The virus was typed as adenovirus type 22 in neutralization tests and was related closely to types 10, 19, and 37 in hemagglutination inhibition tests. The DNA cleavage patterns of the eight strains with nine restriction endonucleases were the same with one exception but different from those of the above serologically related species. We conclude that the intermediate adenovirus is a new etiological agent of conjunctivitis, mainly epidemic keratoconjunctivitis.
Human adenovirus is composed of 41 species plus six candidate species so far (6, 18) and divided into six different subgenera, A to F, based on their DNA homology (15) . Among them, the 23 established species of subgenus D, which agglutinate rat erythrocytes as a common characteristic, are genetically closely related, and therefore some serological cross-reactions between different prototypes are observed (19) . Furthermore, serologically intermediate-type isolates of adenovirus, which relate to one prototype in neutralization and to another in hemagglutination inhibition (HI), have been reported, mostly in subgenus D (17) .
On the other hand, medically important species in subgenus D are adenovirus types 8, 19 , and 37 (15) . They mainly cause epidemic keratoconjunctivitis (EKC). In the course of a virological investigation of conjunctivitis begun in April 1983 in Hiroshima City, Japan (8), we have isolated eight strains of an uncommon adenovirus which differed from established adenoviruses as a causative agent of conjunctivitis. They were typed as adenovirus type 22 in neutralization tests and found to be closely related to types 10, 19 , and 37 in HI tests.
In this article, we tentatively designate these viruses adenovirus type 22/H10,19,37 (Ad22/H10,19,37) and characterize them serologically and genetically. conjunctival swab specimens taken from eight patients aged 20 to 47 years in the acute phase of conjunctivitis. Of the eight cases, six were clinically diagnosed as EKC, one as acute hemorrhagic conjunctivitis, and the other as acute conjunctivitis. No other virus was isolated from these samples. No information about the epidemiological relationships among the patients was obtained.
MATERIALS AND METHODS

Clinical
All eight strains were easily isolated in both HEp-2 cells and human embryo fibroblast cells, and four of them were also isolated in RD-18S cells. Ad22/H10,19,37 showed typical round-type CPE in the HEp-2 cells.
HA activity of Ad22tH10,19,37. Table 2 shows the HA activities on various animal erythrocytes of Ad22/H10,19,37 and the reference strains. Ad22/H10,19,37 completely agglutinated rat erythrocytes, indicating that this virus is in subgenus D. The virus also agglutinated human 0, guinea pig, and mouse erythrocytes at almost the same titers as rat erythrocytes and green and cynomolgus monkey erythrocytes at significantly lower titers.
Among the strains tested, the HA pattern of Ad22/ H10,19,37 was the same as that of Adl9 strains isolated in Hiroshima City (Adl9a) (12) .
Identification of Ad22/H10,19,37 by NT tests. All Ad22/ H10,19,37 strains were neutralized by anti-Ad22 prototype serum; conversely, Ad22 prototype was neutralized by both anti-87006C and anti-88249C sera, indicating that the strains are serotyped as Ad22 by NT tests (Table 3) . Weak crossreactions (delay of CPE) were observed among Ad22/ H10,19,37, AdlO, Adl9, and Ad37.
No prototype of Adl through Ad4l (except Ad36 and Ad38, which were not available at our laboratory) was neutralized by the anti-88249C serum, and two strains of Ad22/H10,19,37 (87006C and 88249C) were not neutralized by antisera against prototypes of Adl through Ad9, Adll results of DNA restriction enzyme analysis also showed that all eight strains of Ad22/H10,19,37 are genetically identical but different from the above-mentioned serologically related viruses. In this study, we could not examine relationships between Ad22/H10,19,37 and some species, especially Ad36 and Ad38. No significant cross-reactivity in the NT and HI tests among Ad36, Ad38, Ad22, AdlO, Adl9, and Ad37 has been observed in other studies (7, 19) . Weak cross-reactions in the NT tests among Ad22/H10,19,37, AdlO, Ad19, and Ad37 may be due to the strong cross-reactivities among them in the HI tests, as described by Wigand et al. (19) .
All Ad22/H10,19,37 strains were isolated from conjunctival swab specimens from eight patients in the acute phase of conjunctivitis. Six of them were from patients diagnosed clinically as having EKC. No other virus was isolated from the same samples. Taking these facts together, we conclude that Ad22/H10,19,37 is a new etiological agent of conjunctivitis, mainly EKC, although we did not confirm the infection of the patients with it serologically.
It is interesting to speculate on the origin of Ad22/ H10,19,37 strains from the viewpoint of the evolution of adenoviruses. Intermediate types of adenoviruses are generally thought to be created by the recombination of two different species (1, 14) . This idea suggests that Ad22/ H10,19,37 is a recombinant of Ad22, with the neutralizationrelated e antigen located outside the hexon (13) and AdlO, Adl9, or Ad37, with the hemagglutinin, or y antigen, located at the top of the fiber (13) . Adl9a seems to be the most plausible candidate from the similarities in the HA pattern (Table 2) , although the results of the HI tests and comigration analysis of the cleaved DNAs cannot conclusively determine whether AdlO, Adl9, or Ad37 is the donor of the hemagglutinin. This hypothesis is supported by the epidemi- (2) . Since then, Ad22 has been isolated rarely (6, 9, 20, 21) . According to World Health Organization reports (20, 21) , only three isolates of Ad22, two from gastroenteritis and one from cardiovascular disease, were reported worldwide from 1981 to 1983. In a virological investigation of diseases, including eye disease (conjunctivitis), in Australia from 1972 to 1979 by Irving et al. (9) , no strain of Ad22 was isolated from eye specimens, though nine strains of Ad22 were isolated from other specimens. These reports suggest that the affinity of Ad22 for the conjunctiva was originally weak, with or without the ability to cause conjunctivitis. It is reasonable to speculate that Ad22 increased its ability to infect the conjunctiva by getting the fiber, which is thought to work on the first step of infection (3), from other species of adenoviruses, with or without a change in some other region of the genome that effects pathogenic processes (5). AdlO, Adl9, and Ad37 have all been shown to be causative agents of conjunctivitis (4, 10, 11, 16) . The idea that Ad22/ H10,19,37 came from the recombination of Ad22 and AdlO, Adl9, or Ad37 may explain the mechanism of the sudden appearance of Adl9a and Ad37 as causative agents of conjunctivitis, as reported previously (4, 10) .
